SCHEMBL4366679

SCHEMBL4366679

CC([C]=O)=CC[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6525170 0.77 KMT2A (0.32)
SCHEMBL4443779 0.77
SCHEMBL820040 0.77
SCHEMBL2164380 0.74
SCHEMBL16322043 0.74
SCHEMBL2164382 0.74
SCHEMBL3058730 0.74
SCHEMBL4985773 0.72 EP300 (0.33)
SCHEMBL2164463 0.70
SCHEMBL2162505 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4392564-A1 MICROBIAL FERMENTATION FOR THE PRODUCTION OF ISOPRENOID ALCOHOLS AND DERIVATIVES Lanzatech, Inc. (US) 2024-07-03 EP claimed
WO-2023028459-A1 MICROBIAL FERMENTATION FOR THE PRODUCTION OF ISOPRENOID ALCOHOLS AND DERIVATIVES LANZATECH, INC. (US) 2023-03-02 WO claimed
EP-3908663-A1 MICROORGANISMS AND METHODS FOR THE PRODUCTION OF OXYGENATED COMPOUNDS FROM HEXOSES Braskem S.A. (BR) 2021-11-17 EP claimed
US-12006526-B2 Microorganisms and methods for the production of oxygenated compounds from hexoses BRASKEM S.A. (BR) 2024-06-11 US disclosed
US-11913073-B2 Methods for assessing risk of developing a viral disease using a genetic test PML SCREENING, LLC (US) 2024-02-27 US disclosed
US-11913074-B2 Methods for assessing risk of developing a viral disease using a genetic test PML SCREENING, LLC (US) 2024-02-27 US disclosed
US-20230265519-A1 METHODS FOR ASSESSING RISK OF DEVELOPING A VIRAL DISEASE USING A GENETIC TEST THE ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS (APHP) (FR) 2023-08-24 US disclosed
US-20230265520-A1 METHODS FOR ASSESSING RISK OF DEVELOPING A VIRAL DISEASE USING A GENETIC TEST PML SCREENING, LLC 2023-08-24 US disclosed
US-11584944-B2 Degradation pathway for pentose and hexose sugars BRASKEM S.A. (BR) 2023-02-21 US disclosed
US-20210381052-A1 METHODS FOR ASSESSING RISK OF DEVELOPING A VIRAL DISEASE USING A GENETIC TEST PML SCREENING, LLC 2021-12-09 US disclosed
US-20210371928-A1 METHODS FOR ASSESSING RISK OF DEVELOPING A VIRAL DISEASE USING A GENETIC TEST The Universite Paris-Sud (FR) 2021-12-02 US disclosed
WO-2014202616-A2 RASAMSONIA GENE AND USE THEREOF DSM IP ASSETS B.V. (NL) 2014-12-24 WO disclosed
US-8722385-B2 Biological synthesis of difunctional hexanes and pentanes from carbohydrate feedstocks CELEXION, LLC (US) 2014-05-13 US disclosed
US-8404465-B2 Biological synthesis of 6-aminocaproic acid from carbohydrate feedstocks CELEXION, LLC (US) 2013-03-26 US disclosed
US-20130017593-A1 Biological Synthesis of Difunctional Hexanes and Pentanes from Carbohydrate Feedstocks CELEXION, LLC (US) 2013-01-17 US disclosed
US-20120301950-A1 BIOLOGICAL SYNTHESIS OF DIFUNCTIONAL HEXANES AND PENTANES FROM CARBOHYDRATE FEEDSTOCKS CELEXION, LLC 2012-11-29 US disclosed
US-20090186358-A1 Pathway Analysis of Cell Culture Phenotypes and Uses Thereof WYETH (US) 2009-07-23 US disclosed
US-20080152641-A1 Inhibitors of Siderophore Biosynthesis in Fungi AUTRIA WIRTSCHAFTSSERVICE 2008-06-26 US disclosed
EP-1723253-A2 INHIBITORS OF SIDEROPHORE BIOSYNTHESIS IN FUNGI Austria Wirtschaftsservice Gesellschaft mbH (AT) 2006-11-22 EP disclosed
WO-2005093036-A2 INHIBITORS OF SIDEROPHORE BIOSYNTHESIS IN FUNGI AUSTRIA WIRTSCHAFTSSERVICE GESELLSCHAFT MBH (AT) 2005-10-06 WO disclosed